Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

Melanotan-2 FAQ: Research Application Comparison

Researchers approach Melanotan-2 from different study angles. Melanogenesis, appetite regulation, or melanocortin pathway characterization. The table below compares primary research applications, typical dosing ranges, observation timelines, and key outcome me

This comparison does not assign a generated winner or score.

  • Researchers approach Melanotan-2 from different study angles. Melanogenesis, appetite regulation, or melanocortin pathway characterization. The table below compares primary research applications, typical dosing ranges, observation timelines, and key outcome measures.
  • Melanogenesis & Pigmentation
  • 300–800 μg/kg subcutaneous
  • Daily
  • 7–14 days
  • Melanin content quantification, tyrosinase activity, visual pigmentation scoring
  • Most robust published data exists here. Well-characterized dose-response curves and established protocols make replication straightforward
  • Appetite Regulation / MC4R Studies
  • 100–500 μg/kg subcutaneous or IP
  • Single acute dose or daily × 3–7 days
  • 4–24 hours (acute) or 7 days (chronic)
  • Food intake measurement, body weight, energy expenditure via indirect calorimetry
  • Appetite effects appear at lower doses than melanogenic effects. Separate dose titration required if studying MC4R-mediated outcomes
  • Receptor Binding & Pathway Mapping
  • 50–1000 μg/kg (wide range for curve generation)
  • Single dose or daily depending on assay
  • Hours to days depending on endpoint
  • Receptor occupancy assays, cAMP quantification, CREB phosphorylation, gene expression (qPCR)
  • Requires multi-dose pilot studies to establish dose-response relationships specific to your model and receptor subtype of interest
  • The bottom line: melanogenic endpoints are the most extensively validated application for MT-2 research. Decades of published protocols provide clear methodological precedent. Appetite and MC4R research requires more careful dose selection because the effective concentration differs significantly from melanogenic doses and shows higher inter-individual variability.
More references

Related material